Letrozole Hilma Biocare

Letrozole by Hilma Biocare, sold medically as Femara, is one of the most powerful aromatase inhibitors available for controlling estrogen. Originally developed to treat hormone-receptor-positive breast cancer, it has become a key ancillary for athletes running aromatizing steroids, prized for its ability to strongly suppress estrogen and even reverse existing gynecomastia. Because it is so potent, it is used carefully and at low doses to keep hormonal balance without crashing estrogen entirely.

Effects and benefits

Letrozole can lower estrogen by up to the high nineties in percentage terms, which is why it is reserved for heavy aromatizing cycles or for reversing gyno that milder inhibitors cannot handle. Controlling estrogen this way also helps limit water retention and supports higher free testosterone.

• Powerfully reduces estrogen levels
• Can reverse existing gynecomastia
• Cuts water retention and bloat
• Supports higher free testosterone

Dosage and administration

Because of its strength, most users run just 0.25–0.5 mg every other day and titrate to bloodwork and symptoms, avoiding an estrogen crash. As an ancillary it belongs in a structured post cycle therapy and on-cycle support plan rather than in the anabolic stack itself.

Stacking and combinations

For lighter cycles many prefer the gentler control of Anastrozole or Exemestane, keeping Letrozole in reserve for heavy aromatization or active gyno.

Why choose Hilma Biocare

Every batch is produced to consistent pharmaceutical standards with dependable dosing you can trust with such a strong compound. Explore the complete Hilma Biocare catalogue to assemble a matching support protocol.